Hepatitis C Virus, NS3, aa1450-1643 (HCV) (Biotin)
Catalog No : USB-208975
531.05€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Hepatitis C Virus, NS3, aa1450-1643 (HCV) (Biotin) | ||
|---|---|---|---|
| Catalog No | USB-208975 | ||
| Supplier’s Catalog No | 208975 | ||
| Supplier | US Biologicals | ||
| Source antigen | E. coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | Highly Purified (~95%) | ||
| Form | Supplied as a liquid in 25mM Tris-Hcl, pH 8, 10mM mercaptoethanol. Labeled with Biotin. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | Highly Purified (~95%) | ||
| Description | HCV is a small 50nm, enveloped, single-stranded, positive sense RNA virus in the family Flaviviridae. HCV has a high rate of replication with ~one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes (1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). Source: Recombinant protein corresponding to the HCV NS3 immunodominant regions, aa1450-1643, expressed in E. coli. Specificity: Immunoreactive with sera of HCV-infected individuals. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved